Pregabalin is predominantly used in the treatment of epilepsy and for anxiety disorders. It can be misused either through overuse of the prescribed amount, or through recreational use. In the last few years, there has been a marked increase in the number of people being prescribed Pregabalin and sadly the number of deaths caused by … Continue reading Pregabalin guidance
Category: Resource
NHS Improvement consulted from December 2018 - February 2019 on proposals for a new national patient safety strategy to support the NHS to be the safest healthcare system in the world. The strategy is being developed alongside the NHS Long Term Plan and will be relevant to all providers of NHS care, including community pharmacy. The … Continue reading Developing the NHS patient safety strategy
The reduction of errors involving Look-Alike Sound-Alike (LASA) is a key focus of the Community Pharmacy Patient Safety Group’s work. LASA errors regularly feature in “share and learn” sessions at our meetings and we have produced a series of resource and materials to support pharmacy teams which are available on this page. The highest risk … Continue reading Look-Alike Sound-Alike medicines
In June 2018, NHS improvement, the British Dietetic Association and the Royal College of Speech and Language therapists issued a Patient Safety Alert regarding the use of food thickening (or texture modifying) products for people with swallowing difficulties (dysphagia). There have been a number of incidents reported to the National Reporting and Learning System (NRLS) … Continue reading Safer modification of food and drink
Valproate medicines are used in the treatment of epilepsy, bipolar disorder and occasionally to prevent migraine headaches. If taken during pregnancy, there is a significant risk that babies may be born with birth defects. Women and girls using valproate medicines must now be protected by a Pregnancy Prevention Programme, which brings valproate in line with other … Continue reading Valproate safety
The Secretary of State for Health and Social Care announced on 6 February 2018 that he was asking Professor Sir Norman Williams to conduct a rapid policy review into the issues pertaining to gross negligence manslaughter in healthcare. Working with stakeholders, the Review considered: how to ensure healthcare professionals are adequately informed about: where and … Continue reading Williams Review
The Centre for Pharmacy Postgraduate Education (CPPE) launched a new patient safety learning campaign, beginning Monday 26 February. This learning campaign uses a real-life patient safety incident to explore inherent risks in pharmacy practice, to support pharmacy professionals to develop and maintain a safer culture. CPPE’s patient safety campaign takes place over six weeks, with … Continue reading CPPE patient safety campaign
In June 2017, a learning module for community pharmacists on the importance of reporting patient safety incidents was published in Pharmacy Magazine. The module was written with input from the Community Pharmacy Patient Safety Group and aims to help pharmacy professionals reflect on how the patient safety incident reports that their teams make contribute to … Continue reading CPD module
NHS Improvement and the MHRA have been reminding healthcare professionals of the fire risks that paraffin-based skin products can cause, following a number of serious incidents and a recent fatality. However, new information about the risk of severe and fatal burns indicates that previous warnings should also extend to paraffin-free emollients - not just paraffin … Continue reading Emollients and fire risks
Most community pharmacies already offer secure medication delivery services to patients in their homes, especially for older or more vulnerable patients. As many pharmacies have reported significant increases in requests for these services from patients and their families, the community pharmacy Patient Safety Group felt that this was an important focus area for improvement across … Continue reading Safer delivery of medicines
Community Pharmacy Patient Safety Group 